Flagship Harbor Advisors LLC Sells 62,502 Shares of Abrdn Life Sciences Investors (NYSE:HQL)

Flagship Harbor Advisors LLC reduced its position in Abrdn Life Sciences Investors (NYSE:HQL) by 20.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 250,441 shares of the company’s stock after selling 62,502 shares during the period. Flagship Harbor Advisors LLC’s holdings in Abrdn Life Sciences Investors were worth $3,286,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of HQL. Cetera Investment Advisers boosted its position in Abrdn Life Sciences Investors by 6.9% in the second quarter. Cetera Investment Advisers now owns 156,384 shares of the company’s stock worth $2,216,000 after purchasing an additional 10,137 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in shares of Abrdn Life Sciences Investors in the second quarter worth approximately $154,000. Future Financial Wealth Managment LLC purchased a new position in shares of Abrdn Life Sciences Investors in the third quarter worth approximately $30,000. International Assets Investment Management LLC bought a new stake in Abrdn Life Sciences Investors during the third quarter valued at approximately $204,000. Finally, Stephens Inc. AR increased its holdings in Abrdn Life Sciences Investors by 7.6% during the third quarter. Stephens Inc. AR now owns 12,707 shares of the company’s stock valued at $192,000 after buying an additional 896 shares during the last quarter. Institutional investors own 32.21% of the company’s stock.

Abrdn Life Sciences Investors Trading Up 0.8 %

Shares of Abrdn Life Sciences Investors stock opened at $14.07 on Friday. Abrdn Life Sciences Investors has a 1-year low of $12.76 and a 1-year high of $15.90. The company’s fifty day simple moving average is $13.76 and its 200-day simple moving average is $14.63.

Abrdn Life Sciences Investors Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Thursday, November 21st were given a dividend of $0.50 per share. The ex-dividend date was Thursday, November 21st. This is an increase from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49. This represents a $2.00 annualized dividend and a yield of 14.22%.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.